Nov 13, 2017
Pharmaceutical Executive
With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.
Nov 07, 2017
While most pharma companies are in partial production using generators, few are operating at 100% capacity, writes Jill Wechsler.
Nov 07, 2017
A year after the Accelerated Access Review explored how to speed up adoption of innovation across the NHS in England, the UK Government has responded. Leela Barham reports.
Nov 06, 2017
Pharmaceutical Executive
Can health stakeholders be friends without being captives? Reflector reports.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
Oct 06, 2017
The UK's Association of the British Pharmaceutical Industry had hoped to stop a new policy that amounts to price negotiation and potentially delaying access to new medicines.
Sep 28, 2017
Leela Barham looks at the reasons behind the Association of the British Pharmaceutical Industry's bid to legally challenge NICE's proposed introduction of the budget impact test.
Sep 05, 2017
Reflector asks if the UK's newly announced post-Brexit life sciences strategy report is worth a look as a springboard to addressing future EU ties in healthcare, or just more bluster?
Sep 04, 2017
Leela Barham casts her eye over the UK's plans for its life sciences industry in the post-Brexit world.
Aug 29, 2017
With a new consultation from the UK’s Department of Health proposing changes to the Statutory Scheme for Pricing of Branded Medicines, what could this mean for negotiation of a successor to the Pharmaceutical Price Regulation Scheme? Leela Barham reports.
lorem ipsum